1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-1742
  5. Product Images: Spironolactone

Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 70518-1742 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Spironolactone is a prescription medication provided in a quantity of 30 HD2 tablets. The medication should be kept out of reach of children and stored at a temperature between 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F), according to USP. Directions for use are available in the package insert. The medication was repackaged by RemedyRepack Inc. in Indiana, PA 15701, with source NDC 16729-0226-16 and an Ack RX ONLY label. The Lot # and expiration date are not available. The medication's manufacturer is Accerd in Durham, NC 27703.*

Spironolactone 50mg 70518 1742 01

Spironolactone 50mg 70518 1742 01

Spironolactone is a medication that comes in a quantity of 30 HD2 and is only available through a prescription. The NDC number for this medication is 70518-1742-01, and the manufacturer is Accerd located in Durham, North Carolina. The lot number and expiration date are not available. The medication should be kept out of reach of children and stored between 20-26°C, although excursions up to 15-30°C are permitted. Directions for use can be found in the package insert. This medication has been repackaged by RemedyRepack Inc. located in Indiana, Pennsylvania.*

Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactone figure 1

Figure 1. Survival by Treatment Group in The Randomized Spironolactone Evaluation Study - spironolactone figure 1

This is not-available.*

Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactone figure 2

Figure 2. Hazard Ratios of All-Cause Mortality by Subgroup in The Randomized Spironolactone Evaluation Study - spironolactone figure 2

This is a table display related to a clinical trial where different subgroups were compared for the effectiveness of Spironolactone and Placebo. The table lists different doses ranging from 0.2 to 1.4 and compares the outcomes against each other. The final column specifies which treatment was more effective, either Spironolactone or Placebo.*

Chemical Structure - spironolactone structure image

Chemical Structure - spironolactone structure image

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.